Main Article Content
Background: The prevalence of breakthrough seizures in persons with epilepsy is very high in developing countries. Consequently, patients and physicians should be aware of the possible factors that may cause breakthrough seizures.
Objective: The aim of our study is to determine the possible factors that may be a precipitating cause for breakthrough seizures in patients with epilepsy.
Methods: This cross-sectional study included 100 persons with epilepsy with idiopathic epilepsy receiving antiepileptic drugs (AEDs). They were divided into two groups. Group 1 included 50 persons with epilepsy with a history of recent breakthrough seizures. Group 2 included 50 persons with epilepsy who had not experienced any recent breakthrough seizures. Patients were subjected to a thorough questionnaire addressing precipitating factors. All participants were subjected to an electroencephalogram (EEG) and medication adherence assessment.
Results: There was no significant differences between group 1 and group 2 regarding age, sex, age of onset of epilepsy, occupation and marital status (P value range 0.5 – 0.2). The patients in group 1 were found to have longer durations of epilepsy, lower adherence to AEDs (P = 0.001), more missed doses of AEDs (P = 0.0001), more side effects of AEDs (P = 0.0005), more sleep deprivation, lower level of AEDs (P = 0.0006), more frequently on AED polytherapy (P = 0.0002), and more flickering lights (P = 0.04) than the participants in group 2. In terms of the EEG, group 1 showed a higher percentage of abnormal EEGs and more frequent focal epileptiform discharges (P = 0.003). Also, pathological findings in MRI brain were associated with higher breakthrough seizures (P = 0.005). No significant difference was found in both group1 and group 2 regarding emotional stress (P = 0.55), substitution of brand AEDs by generic one (P = 0.83), concurrent illness (P = 1), or the use of non AEDs (P = 0.79).
Conclusion: The precipitating factors of breakthrough seizures are multifactorial and it is very important to educate patients about these precipitating factors to achieve better control of epilepsy.
Mary Jane England, Catharyn T. Liverman, Andrea M. Schultz, Larisa M. Strawbridge. A reprint from epilepsy across the spectrum: Promoting health and understanding. Epilepsy Curr. 2012;12(6): 245–253.
Joseph I. Sirven. Epilepsy: A spectrum disorder. Cold spring harb perspect med. 2015;5(9):a022848. DOI: 10.1101/cshperspect.a022848.
Ba - Diop A, Marin B, Druet - Cabanac M, Ngoungou EB, Newton CR, Preux PM. Epidemiology, causes and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol. 2014;13(10):1029-44.
El - Tallawy HN, Farghaly WM, Shehata GA, Abdel - Hakeem NM, Rageh TA, et al. Epidemiology of epilepsy in New Valley Governorate, Al Kharga District, Egypt. Epilepsy Res. 2012;104: 167-174.
Tang F, Hartz AMS, Bauer B. Drug-resistant epilepsy: Multiple hypotheses, few answers. Front. Neurol. 2017;8:301.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069–1077.
Laura J. Bonnett, Catrin Tudur Smith, Sarah Donegan, Anthony G. Marson, Treatment outcome after failure of a first antiepileptic drug. Neurology. 2014;83(6): 552–560.
Martin Kaddumukasa, Mark Kaddumukasa, Steven Matovu, Elly Katabira. The frequency and precipitating factors for breakthrough seizures among patients with epilepsy in Uganda. BMC Neurol. 2013;13:182.
Yirga Legesse Niriayo, Abraham Mamo, Kidu Gidey, Gebre Teklemariam Demoz. Medication belief and adherence among patients with epilepsy. Behavioural Neurology; 2019.
Article ID 2806341, 7 pages
Boris Garber, Jonathan Glauser. Evaluation and management of seizures in the Emergency Department. Emergency Medicine Report; 2017.
Ingrid E Scheffer, Samuel Berkovic, Giuseppe Capovilla, Mary B Connolly, Jacqueline French, Laura Guilhoto, et al. ILAE classification of the epilepsies position paper of the ILAE Commission for classification and terminology. Epilepsia. 2017;58(4):512–521. DOI: 10.1111/epi.13709
Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA. Which seizure precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav. 2005;6:85-89.
Pande Ayu, Naya Kasih Permatananda, Putu Indah, Budi Apsari, Saktivi Harkitasari, Permatananda Pande. Medication adherence and quality of life among epilepsy patients: A cross sectional study. International Journal of Research. 2019;(7):1-10.
Jose R. Rodriguez - Gomez, Damaris Pagan - Torres. The importance of treatment adherence in the well being of the patient: A brief literature review. American Journal of Medicine and Medical Sciences. 2018; 8(1):318-323.
Manal Al-Kattan, Lamia Afifi, Reham Shamloul, Emad El Din Mostafa. Assessment of precipitating factors of breakthrough seizures in epileptic patients. Egyptian Journal of Neurology, Psychiatry, and Neurosurgery. 2015; 52(3):165-171.
Shereen A El-Awady, Eman A Elsheshtawy, Wafaa A Elbahaey, Osama A Elboraie. Impact of familial risk factors on the severity of addiction in a sample of Egyptian adolescents. Egyptian Journal of Psychiatry. 2017; 38(2):70-78.
Martin Kaddumukasa, Mark Kaddumukasa, Steven Matovu, Elly Katabira. The frequency and precipitating factors for breakthrough seizures among patients with epilepsy in Uganda. BMC Neurology. 2013,13:182.
Joseph I. Sirven. Epilepsy: A spectrum disorder cold spring harb perspect med. 2015;5(9):a022848.
Rajagopalan K, Candrilli SD, Ajmera M. Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs. Dove Press. 2018;10:619—627.
Asmamaw Getnet, Solomon Meseret Woldeyohannes, Lulu Bekana, Tesfa Mekonen, Wubalem Fekadu, et al. Antiepileptic drug nonadherence and its predictors among people with epilepsy. Behav Neurol. 2016;3189108.
Trevor Resnick, Edward Faught R. Compliance and the prevention of breakthrough seizures: Discussion on improving patient adherence to newer anti-epileptic drugs to prevent breakthrough seizures. Neurology Live; 2019.
Azra Zafar, Rizwana Shahid, Saima Nazish, Danah Aljaafari, Fahd Ali Alkhamis, et al. Nonadherence to antiepileptic medications: Still a major issue to be addressed in the management of epilepsy. Journal of Neurosciences in Rural Practice. 2019;10(1):106-112.
Bosak M, Słowik A, Turaj W. Safety of switching from brand-name to generic levetiracetam in patients with epilepsy. DovePress 2017;11:2287—2291.
Hsien Yi Chen, Timothy E. Albertson, Kent R. Olson. Treatment of drug induced seizures. Br J Clin Pharmacol. 2016;81(3): 412–419.
Alan B Ettinger, Radhika K. Adiga breakthrough seizures — Approach to prevention and diagnosis. US Neurology, 2008;4(1):40-42.
Samsonsen C1, S, T2, Bråthen G2, Helde G3, Brodtkorb E2. The impact of sleep loss on the facilitation of seizures: A prospective case-crossover study. Epilepsy Res. 2016;127:260-266.
Ferlisi M1, Shorvon S2. Seizure precipitants (triggering factors) in patients with epilepsy. Epilepsy Behav. 2014;33:101-5.
Epub 2014 Mar 15.
Heather R, McKee Michael D. Privitera. Stress as a seizure precipitant: Identification, associated factors and treatment options. Seizure. 2017;44:21-26. Available:https://doi.org/10.1016/j.seizure.2016.12.009
Zeynep Vildan Okudan1, Çiğdem Özkara2. Reflex epilepsy: Triggers and management strategies. Neuropsychiatr Dis Treat. 2018; 14:327–337.
Madhuradhar Chegondi, Mary M. Garland, Prithvi Sendi, Anuj R. Jayakar, Balagangadhar R. Totapally. Course and outcome of children with convulsive status epilepticus admitted to a pediatric intensive care unit. Cureus. 2019;11(4): e4471.
Sudhir Kumar. Factors precipitating seizures in well-controlled epilepsy. Indian pediatrics. 2005;42(2):182-3.
Zhibin Chen, Martin J. Brodie, Danny Liew, Patrick Kwan, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic. A 30 Year Cohort Study. JAMA Neurol. 2018;75(3):279-286.